Basic Information
| RNALocate ID: | RLID-D:02000618 |
| RNA Symbol: | MALAT1 |
| Localization: | Cytosol |
RNA Information
| RNA Name: | MALAT1 |
| RNA ID: | NCBI:378938|Ensembl:ENSG00000251562 |
| RNA Category: | lncRNA |
| Species: | Homo sapiens |
| Alias: | HCN|LINC00047|NCRNA00047|NEAT2|PRO2853 |
Localization Information
| Tissue/Cell Line: | HCC cell line (HepG2)|HeLa-S3 cells|K562 cells |
| Database: | CSCD |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:02000386 | Nucleus | ZFL cells | 28538188 |
| RLID:02000501 | Chromatin | Breast cancer cell line (SKBR3) | 28652379 |
| RLID:02000502 | Cytoplasm | HEK-293T cells|Mammary epithelium cell line (HC11) | 31863590 |
| RLID:02000503 | Cytosol | Human myelogenous leukemia cell line (K-562) | 21613539 |
| RLID:02000504 | Mitochondrion | HCC cell line (HepG2) | 31218107 |
| RLID:02000505 | Nucleus | Human osteosarcoma cell line (U2OS) | 28423669 |
| RLID:02000506 | Nucleus | HeLa cells | 28663102 |
| RLID:02000507 | Nucleus | WI-38 cells | 29133588 |
| RLID:02000508 | Nucleus | Human brain microvascular endothelial cells | 30419554 |
| RLID:02000509 | Nuclear speckle | Breast cancer cell line (MCF-7) | 28652379 |
| RLID:02000510 | Nuclear speckle | Retinal microvascular endothelial cells | 30815547 |
| RLID:02000511 | Nuclear speckle | U2OS cells | 31085639 |
| RLID:02000512 | Nuclear speckle | HEK-293T cells|Mammary epithelium cell line (HC11) | 31863590 |
| RLID:02000513 | Nuclear speckle | HeLa-TO cells | 22355166 |
| RLID:02000514 | Nucleoplasm | WI-38 cells | 29133588 |
| RLID:02000515 | Nucleus | Human cervical cancer cell line (HeLa) | 28216671 |
| RLID:02000516 | Nucleus | U2OS cells | 28538188 |
| RLID:02000517 | Nucleus | Breast cancer cell lines (MDA-MB-468|SKBR3) | 28652379 |
| RLID:02000518 | Nucleus | HeLa cells | 29335281 |
| RLID:02000519 | Nucleus | Lung cancer cell line (A549) | 30548064 |
| RLID:02000520 | Nucleus | Vascular smooth muscle cells | 31696492 |
| RLID:02000521 | Nucleus | Fibroblasts|Lymphoblasts | 17270048 |
| RLID:02000522 | Nucleus | Cell line (HeLa) | 19041754 |
| RLID:02000523 | Nucleus | HeLa cells | 20797886 |
| RLID:02000524 | Nucleus | Motor neurons | 22070123 |
| RLID:02000525 | Nucleus | Human cervical cancer cell line (HeLa) | 22078878 |
| RLID:02000526 | Nucleus | CLTon cells | 22855529 |
| RLID:02000527 | Nucleus | HeLa cells | 23073843 |
| RLID:02000528 | Nucleus | Cell line (HeLa) | 23152763 |
| RLID:02000529 | Nucleus | Colon cancer cells | 24393600 |
| RLID:02000530 | Nucleus | HeLa cells | 25630241 |
| RLID:02001011 | Nucleus | IgH-2 cells|Periphery of seminiferous tubules | 28538188 |
| RLID:02001145 | Cytoplasm | Lung cancer cell lines (A549|H1299) | 34012919 |
| RLID:12000064 | Exosome | Thyroid papillary carcinoma cell line (TPC-1) | 29967342 |
| RLID:12000065 | Exosome | HeLa cells | 24205503 |
| RLID:22000052 | Speckle periphery | HeLa cells|WI-38 cells | 29133588 |
| RLID-D:02000317 | Chromatin | HeLa-S3 cells|K562 cells | |
| RLID-D:02000717 | Insoluble cytoplasm | K562 cells | |
| RLID-D:02000824 | Membrane | HCC cell line (HepG2)|K562 cells | |
| RLID-D:02001085 | Nucleolus | K562 cells | |
| RLID-D:02001487 | Nucleoplasm | K562 cells | |
| RLID-D:02002025 | Nucleus | HCC cell line (HepG2)|HeLa-S3 cells|K562 cells | |
| RLID-D:12004468 | Exosome | Serum |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | MALAT1 | Anaplastic large cell lymphoma | MNDR-E-LNC-17626 |
| MNDR | MALAT1 | Diffuse large b cell lymphoma | MNDR-E-LNC-17627 |
| MNDR | MALAT1 | Mantle cell lymphoma | MNDR-E-LNC-17628 |
| MNDR | MALAT1 | Oral tongue squamous cell carcinoma | MNDR-E-LNC-17629 |
| MNDR | MALAT1 | Oral squamous cell carcinoma | MNDR-E-LNC-17630 |
| MNDR | MALAT1 | Fibroma | MNDR-E-LNC-17631 |
| MNDR | MALAT1 | Triple negative breast cancer | MNDR-E-LNC-17632 |
| MNDR | MALAT1 | Nonalcoholic fatty liver disease | MNDR-E-LNC-17633 |
| MNDR | MALAT1 | Anaplastic thyroid cancer | MNDR-E-LNC-17634 |
| MNDR | MALAT1 | Prostate cancer | MNDR-E-LNC-17635 |
| MNDR | MALAT1 | Silicosis | MNDR-E-LNC-17636 |
| MNDR | MALAT1 | Chronic lymphocytic leukemia | MNDR-E-LNC-17637 |
| MNDR | MALAT1 | Gastric cancer | MNDR-E-LNC-17638 |
| MNDR | MALAT1 | Pre-eclampsia | MNDR-E-LNC-17639 |
| MNDR | MALAT1 | Alzheimer disease | MNDR-E-LNC-17640 |
| MNDR | MALAT1 | Bladder cancer | MNDR-E-LNC-17641 |
| MNDR | MALAT1 | Gestational diabetes | MNDR-E-LNC-17642 |
| MNDR | MALAT1 | Seizures | MNDR-E-LNC-17643 |
| MNDR | MALAT1 | Lung cancer | MNDR-E-LNC-17644 |
| MNDR | MALAT1 | Diabetic cataract | MNDR-E-LNC-17645 |
| MNDR | MALAT1 | Parkinson disease | MNDR-E-LNC-17646 |
| MNDR | MALAT1 | Primary pulmonary hypertension | MNDR-E-LNC-17647 |
| MNDR | MALAT1 | Breast cancer | MNDR-E-LNC-17648 |
| MNDR | MALAT1 | Cancer | MNDR-E-LNC-17649 |
| MNDR | MALAT1 | Squamous cell carcinoma | MNDR-E-LNC-17650 |
| MNDR | MALAT1 | Thyroid cancer | MNDR-E-LNC-17651 |
| MNDR | MALAT1 | Pancreatic cancer | MNDR-E-LNC-17652 |
| MNDR | MALAT1 | Malignant melanoma | MNDR-E-LNC-17653 |
| MNDR | MALAT1 | Atherosclerosis | MNDR-E-LNC-17654 |
| MNDR | MALAT1 | Vulva squamous cell carcinoma | MNDR-E-LNC-17655 |
| MNDR | MALAT1 | Epithelial ovarian cancer | MNDR-E-LNC-17656 |
| MNDR | MALAT1 | Colon cancer | MNDR-E-LNC-17657 |
| MNDR | MALAT1 | Hepatitis | MNDR-E-LNC-17658 |
| MNDR | MALAT1 | Ovarian cancer | MNDR-E-LNC-17659 |
| MNDR | MALAT1 | Laryngeal and hypopharyngeal carcinoma | MNDR-E-LNC-17660 |
| MNDR | MALAT1 | Kidney cancer | MNDR-E-LNC-17661 |
| MNDR | MALAT1 | Urothelial cancer | MNDR-E-LNC-17662 |
| MNDR | MALAT1 | Infantile hemangioma | MNDR-E-LNC-17663 |
| MNDR | MALAT1 | Carcinoma endometrioid | MNDR-E-LNC-17664 |
| MNDR | MALAT1 | Endometrial carcinoma | MNDR-E-LNC-17665 |
| MNDR | MALAT1 | Laryngeal squamous cell cancer | MNDR-E-LNC-17666 |
| MNDR | MALAT1 | Endometriosis | MNDR-E-LNC-17667 |
| MNDR | MALAT1 | DH1/2 wild-type primary GB tumor | MNDR-E-LNC-17668 |
| MNDR | MALAT1 | Astrocytoma | MNDR-E-LNC-17669 |
| MNDR | MALAT1 | Glioma | MNDR-E-LNC-17670 |
| MNDR | MALAT1 | Gastrointestinal system cancer | MNDR-E-LNC-17671 |
| MNDR | MALAT1 | Gallbladder cancer | MNDR-E-LNC-17672 |
| MNDR | MALAT1 | Skin squamous cell carcinoma | MNDR-E-LNC-17673 |
| MNDR | MALAT1 | Amyotrophic lateral sclerosis | MNDR-E-LNC-17674 |
| MNDR | MALAT1 | Osteosarcoma | MNDR-E-LNC-17675 |
| MNDR | MALAT1 | Fibrosarcoma | MNDR-E-LNC-17676 |
| MNDR | MALAT1 | Ewing sarcoma | MNDR-E-LNC-17677 |
| MNDR | MALAT1 | Pancreatic ductal adenocarcinoma | MNDR-E-LNC-17678 |
| MNDR | MALAT1 | Liver cancer | MNDR-E-LNC-17679 |
| MNDR | MALAT1 | Choriocarcinoma | MNDR-E-LNC-17680 |
| MNDR | MALAT1 | Uterine cancer | MNDR-E-LNC-17681 |
| MNDR | MALAT1 | Gastric adenocarcinoma | MNDR-E-LNC-17682 |
| MNDR | MALAT1 | Esophagus squamous cell carcinoma | MNDR-E-LNC-17683 |
| MNDR | MALAT1 | Pulmonary fibrosis | MNDR-E-LNC-17684 |
| MNDR | MALAT1 | Pituitary adenoma | MNDR-E-LNC-17685 |
| MNDR | MALAT1 | Lung squamous cell carcinoma | MNDR-E-LNC-17686 |
| MNDR | MALAT1 | Carcinoma lung non-small-cell | MNDR-E-LNC-17687 |
| MNDR | MALAT1 | Lung adenocarcinoma | MNDR-E-LNC-17688 |
| MNDR | MALAT1 | Adrenocortical carcinoma | MNDR-E-LNC-17689 |
| MNDR | MALAT1 | Follicular thyroid carcinoma | MNDR-E-LNC-17690 |
| MNDR | MALAT1 | Papillary thyroid cancer | MNDR-E-LNC-17691 |
| MNDR | MALAT1 | Medullary thyroid carcinoma | MNDR-E-LNC-17692 |
| MNDR | MALAT1 | Thyroid medullary carcinoma | MNDR-E-LNC-17693 |
| MNDR | MALAT1 | Ovarian carcinoma | MNDR-E-LNC-17694 |
| MNDR | MALAT1 | Bladder urothelial carcinoma | MNDR-E-LNC-17695 |
| MNDR | MALAT1 | Bladder carcinoma | MNDR-E-LNC-17696 |
| MNDR | MALAT1 | Hyperglycemia | MNDR-E-LNC-17697 |
| MNDR | MALAT1 | Endometrial stromal sarcoma | MNDR-E-LNC-17698 |
| MNDR | MALAT1 | Uterine corpus endometrial stromal sarcoma | MNDR-E-LNC-17699 |
| MNDR | MALAT1 | Cervical cancer | MNDR-E-LNC-17700 |
| MNDR | MALAT1 | Renal cell carcinoma | MNDR-E-LNC-17701 |
| MNDR | MALAT1 | Clear cell renal cell carcinoma | MNDR-E-LNC-17702 |
| MNDR | MALAT1 | Histiocytoid hemangioma | MNDR-E-LNC-17703 |
| MNDR | MALAT1 | Gorham's disease | MNDR-E-LNC-17704 |
| MNDR | MALAT1 | Pancreatic carcinoma | MNDR-E-LNC-17705 |
| MNDR | MALAT1 | Hilar cholangiocarcinoma | MNDR-E-LNC-17706 |
| MNDR | MALAT1 | Cholangiocarcinoma | MNDR-E-LNC-17707 |
| MNDR | MALAT1 | Esophageal cancer | MNDR-E-LNC-17708 |
| MNDR | MALAT1 | Liver cirrhosis | MNDR-E-LNC-17709 |
| MNDR | MALAT1 | HIV | MNDR-E-LNC-17710 |
| MNDR | MALAT1 | Lung small cell carcinoma | MNDR-E-LNC-17711 |
| MNDR | MALAT1 | Head and neck squamous cell carcinoma | MNDR-E-LNC-17712 |
| MNDR | MALAT1 | Kidney diseases | MNDR-E-LNC-17713 |
| MNDR | MALAT1 | Myocardial infarction | MNDR-E-LNC-17714 |
| MNDR | MALAT1 | Uveal melanoma | MNDR-E-LNC-17715 |
| MNDR | MALAT1 | Aortic valve disease | MNDR-E-LNC-17716 |
| MNDR | MALAT1 | Ovarian endometrial cancer | MNDR-E-LNC-17717 |
| MNDR | MALAT1 | Acute monocytic leukemia | MNDR-E-LNC-17718 |
| MNDR | MALAT1 | Bladder transitional cell carcinoma | MNDR-E-LNC-17719 |
| MNDR | MALAT1 | Ischemic stroke | MNDR-E-LNC-17720 |
| MNDR | MALAT1 | Endometrioid endometrial cancer | MNDR-E-LNC-17721 |
| MNDR | MALAT1 | Hepatocellular carcinoma | MNDR-E-LNC-17722 |
| MNDR | MALAT1 | Hepatoblastoma | MNDR-E-LNC-17723 |
| MNDR | MALAT1 | B-cell lymphoma | MNDR-E-LNC-17724 |
| MNDR | MALAT1 | Rheumatoid arthritis | MNDR-E-LNC-17725 |
| MNDR | MALAT1 | Retinoblastoma | MNDR-E-LNC-17726 |
| MNDR | MALAT1 | Neuroblastoma | MNDR-E-LNC-17727 |
| MNDR | MALAT1 | Osteoarthritis | MNDR-E-LNC-17728 |
| MNDR | MALAT1 | Retinal degeneration | MNDR-E-LNC-17729 |
| MNDR | MALAT1 | Monocytic leukemia | MNDR-E-LNC-17730 |
| MNDR | MALAT1 | Chronic myeloid leukemia | MNDR-E-LNC-17731 |
| MNDR | MALAT1 | Tongue cancer | MNDR-E-LNC-17732 |
| MNDR | MALAT1 | Diabetic retinopathy | MNDR-E-LNC-17733 |
| MNDR | MALAT1 | Systemic lupus erythematosus | MNDR-E-LNC-17734 |
| MNDR | MALAT1 | Acute myeloid leukemia | MNDR-E-LNC-17735 |
| MNDR | MALAT1 | Colorectal cancer | MNDR-E-LNC-17736 |
| MNDR | MALAT1 | Nasopharyngeal carcinoma | MNDR-E-LNC-17737 |
| MNDR | MALAT1 | Nasopharynx carcinoma | MNDR-E-LNC-17738 |
| MNDR | MALAT1 | Diabetes mellitus | MNDR-E-LNC-17739 |
| MNDR | MALAT1 | Type 2 diabetes mellitus | MNDR-E-LNC-17740 |
| MNDR | MALAT1 | Acute myocardial infarction | MNDR-E-LNC-17741 |
| MNDR | MALAT1 | Fatty liver disease | MNDR-E-LNC-17742 |
| MNDR | MALAT1 | Multiple myeloma | MNDR-E-LNC-17743 |
| MNDR | MALAT1 | Extramedullary myeloma | MNDR-E-LNC-17744 |
| MNDR | MALAT1 | Proliferative vitreoretinopathy | MNDR-E-LNC-17745 |
| MNDR | MALAT1 | TDP-43 protein human | MNDR-E-LNC-17746 |
| MNDR | MALAT1 | Aortic valve calcification | MNDR-E-LNC-17747 |
| MNDR | MALAT1 | Ovarian epithelial cancer | MNDR-E-LNC-17748 |
| MNDR | MALAT1 | Esophageal squamous cancer | MNDR-E-LNC-17749 |
| MNDR | MALAT1 | Bronchopulmonary dysplasia | MNDR-E-LNC-17750 |
| MNDR | MALAT1 | Uterine cervical neoplasms | MNDR-E-LNC-17751 |
| MNDR | MALAT1 | Diabetic nephropathies | MNDR-E-LNC-17752 |
| MNDR | MALAT1 | Nasopharyngeal cancer | MNDR-E-LNC-17753 |
| MNDR | MALAT1 | Prostate | MNDR-E-LNC-17754 |
| MNDR | MALAT1 | Spinal cord injury | MNDR-E-LNC-17755 |
| MNDR | MALAT1 | Flavivirus infections | MNDR-E-LNC-17756 |
| MNDR | MALAT1 | Sepsis | MNDR-E-LNC-17757 |
| MNDR | MALAT1 | Nk/t cell lymphoma | MNDR-E-LNC-17758 |
| MNDR | MALAT1 | Acute lung injury | MNDR-E-LNC-17759 |
| MNDR | MALAT1 | Diabetic cardiomyopathies | MNDR-E-LNC-17760 |
| MNDR | MALAT1 | Congenital microtia | MNDR-E-LNC-17761 |
| MNDR | MALAT1 | Calcific aortic valve disease | MNDR-E-LNC-17762 |
| MNDR | MALAT1 | Cardiomyocyte apoptosis | MNDR-E-LNC-17763 |
| MNDR | MALAT1 | Cerebral ischemia-reperfusion injury | MNDR-E-LNC-17764 |
| MNDR | MALAT1 | Cutaneous squamous cell carcinoma | MNDR-E-LNC-17765 |
| MNDR | MALAT1 | Decreased myogenesis | MNDR-E-LNC-17766 |
| MNDR | MALAT1 | EndMT-related diseases | MNDR-E-LNC-17767 |
| MNDR | MALAT1 | High glucose-induced podocyte injury | MNDR-E-LNC-17768 |
| MNDR | MALAT1 | Lymph node metastasis | MNDR-E-LNC-17769 |
| MNDR | MALAT1 | Photo-aging | MNDR-E-LNC-17770 |
| MNDR | MALAT1 | Plexiform fibromyxoma | MNDR-E-LNC-17771 |
| MNDR | MALAT1 | Renal ischemia-reperfusion injury | MNDR-E-LNC-17772 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCA1 | Homo sapiens | RR00022040 |
TOP